Out of Sight, Not out of Mind: Mood Disorders in the Dialysis Unit
November 08, 2019 | 10:30 AM - 12:30 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Clinical Practice Session
Out of Sight, Not out of Mind: Mood Disorders in the Dialysis Unit
November 08, 2019 | 10:30 AM - 12:30 PM
Location: 146 A/B, Walter E. Washington Convention Center
Session Description
Mood disorders are common among individuals on dialysis, but nephrologists often do not have up-to-date training in the diagnosis and management of these conditions. As the depression measure enters the US ESRD Quality Incentive Program, detection rates are poised to rise, and professionals must be equipped to manage patients appropriately. In addition, there may be special cardiovascular safety considerations when prescribing medications to treat mood disorders in this complex population.
Learning Objective(s)
- Describe a patients perspective on mental health disorders in dialysis
- Formulate an approach to the management of depression among individuals receiving dialysis
- Formulate an approach to the management of anxiety among individuals receiving dialysis
- Discuss potential risks of pharmacologic approaches to management of mental health disorders in the dialysis population
Learning Pathway(s)
Moderators
- Susan Hedayati, MD, MS, FASN
- David M. White
Presentations
-
International Trends in Mood Disorders in the Dialysis Population
10:30 AM - 11:00 AM
Bruce M. Robinson, MD, MS, FASN
Bruce M. Robinson, MD, MS, FASN
Bruce Robinson, MD, MS, FACP, is Vice President of Clinical Research at Arbor Research Collaborative for Health, Ann Arbor, Michigan, USA. Dr. Robinson obtained his medical degree at the University of Michigan, and post-graduate training in nephrology and an MS in Clinical Epidemiology at the University of Pennsylvania. Dr. Robinson has been Principal Investigator of the Dialysis Outcomes and Practice Patterns Study (DOPPS) Program since 2009, leading its longstanding international hemodialysis cohort study (DOPPS, since 1996) and the launch of studies in peritoneal dialysis (PDOPPS) and advanced chronic kidney disease (CKDopps). Dr. Robinson has research expertise in quantitative analysis for observational studies of patients with advanced chronic kidney disease and end-stage kidney disease, including the epidemiology of these conditions, the period of transition to kidney failure, and the effects of policy on clinical practice.
International Trends in Mood Disorders in the Dialysis Population
November 08, 2019 | 10:30 AM - 11:00 AM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
-
Management of Depressive Disorders in the Dialysis Population
11:00 AM - 11:30 AM
Rajnish Mehrotra, MD, MBBS, FASN
Rajnish Mehrotra, MD, MBBS, FASN
Management of Depressive Disorders in the Dialysis Population
November 08, 2019 | 11:00 AM - 11:30 AM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
-
Anxiety in Dialysis: Undertreated or Overtreated?
11:30 AM - 12:00 PM
Daniel Cukor, PhD
Daniel Cukor, PhD
Dr. Cukor is currently the Director of Behavioral Health at The Rogosin Institute in New York City. He is a Clinical Health Psychologist engaged in research and clinical care. The bulk of his work has focused on psychosocial issues in patients with end stage renal disease. His current clinical and research interests are focused on depression, anxiety, sleep difficulty, pain and caregiver burden in patients with end stage renal disease.
Anxiety in Dialysis: Undertreated or Overtreated?
November 08, 2019 | 11:30 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
-
Cardiovascular Safety Considerations When Prescribing Mood-Related Drugs to the Dialysis Population
12:00 PM - 12:30 PM
Magdalene M. Assimon, PharmD, PhD
Magdalene M. Assimon, PharmD, PhD
Cardiovascular Safety Considerations When Prescribing Mood-Related Drugs to the Dialysis Population
November 08, 2019 | 12:00 PM - 12:30 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
